日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Cell targeting by the bicomponent leukocidin subunit HlgB drives Staphylococcus aureus pathophysiology

双组分白细胞毒素亚基HlgB的细胞靶向作用驱动金黄色葡萄球菌的病理生理过程。

Cheson, Bruce D; Bartlett, Nancy L; Knopf, Betsy; Lee, Hun J; Advani, Ranjana H; Christian, Beth; Diefenbach, Catherine S; Feldman, Tatyana A; Ansell, Stephen M; Sproch, Julia; Prescott, Rachel; Kim, Hee Jin; Chaguza, Chrispin; Gonzalez, Sandra; Ilmain, Juliana K; Shopsin, Bo; Ratner, Adam J; Torres, Victor J

Myeloablative vs nonmyeloablative consolidation for primary central nervous system lymphoma: results of Alliance 51101

原发性中枢神经系统淋巴瘤的清髓性巩固治疗与非清髓性巩固治疗:Alliance 51101 研究结果

Batchelor, Tracy T; Giri, Sharmila; Ruppert, Amy S; Geyer, Susan M; Smith, Scott E; Mohile, Nimish; Swinnen, Lode J; Friedberg, Jonathan W; Kahl, Brad S; Bartlett, Nancy L; Hsi, Eric D; Cheson, Bruce D; Wagner-Johnston, Nina; Nayak, Lakshmi; Leonard, John P; Rubenstein, James L

Positron Emission Tomography-Adapted Therapy in Bulky Stage I/II Classic Hodgkin Lymphoma: CALGB 50801 (Alliance)

正电子发射断层扫描适应性治疗巨大型 I/II 期经典霍奇金淋巴瘤:CALGB 50801(联盟)

LaCasce, Ann S; Dockter, Travis; Ruppert, Amy S; Kostakoglu, Lale; Schöder, Heiko; Hsi, Eric; Bogart, Jeffrey; Cheson, Bruce; Wagner-Johnston, Nina; Abramson, Jeremy; Blum, Kristie; Leonard, John P; Bartlett, Nancy L

Relevance of Bone Marrow Biopsies for Response Assessment in US National Cancer Institute National Clinical Trials Network Follicular Lymphoma Clinical Trials

骨髓活检在美国国家癌症研究所国家临床试验网络滤泡性淋巴瘤临床试验疗效评估中的意义

Rutherford, Sarah C; Yin, Jun; Pederson, Levi; Perez Burbano, Gabriela; LaPlant, Betsy; Shadman, Mazyar; Li, Hongli; LeBlanc, Michael L; Kenkre, Vaishalee P; Hong, Fangxin; Blum, Kristie A; Dockter, Travis; Martin, Peter; Jung, Sin-Ho; Grant, Barbara; Rosenbaum, Cara; Ujjani, Chaitra; Barr, Paul M; Unger, Joseph M; Cheson, Bruce D; Bartlett, Nancy L; Kahl, Brad; Friedberg, Jonathan W; Mandrekar, Sumithra J; Leonard, John P

Safety and efficacy of atezolizumab with rituximab and CHOP in previously untreated diffuse large B-cell lymphoma

阿特珠单抗联合利妥昔单抗和CHOP方案治疗既往未接受治疗的弥漫性大B细胞淋巴瘤的安全性和有效性

Younes, Anas; Burke, John M; Cheson, Bruce D; Diefenbach, Catherine S; Ferrari, Silvia; Hahn, Uwe H; Hawkes, Eliza A; Khan, Cyrus; Lossos, Izidore S; Musuraca, Gerardo; Tani, Monica; Vitolo, Umberto; Yuen, Sam; Raval, Aparna; Shivhare, Mahesh; Nielsen, Tina G; Sellam, Gila; Sharman, Jeff P

Application of the Lugano Classification for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The PRoLoG Consensus Initiative (Part 1-Clinical)

Lugano 分类在霍奇金淋巴瘤和非霍奇金淋巴瘤的初始评估、分期和疗效评估中的应用:PRoLoG 共识倡议(第 1 部分 - 临床)

Ricard, Fabien; Cheson, Bruce; Barrington, Sally; Trotman, Judith; Schmid, Annette; Brueggenwerth, Guenther; Salles, Gilles; Schwartz, Larry; Goldmacher, Greg; Jarecha, Rudresh; Narang, Jayant; Broussais, Florence; Galette, Paul; Liu, Min; Bajpai, Surabhi; Perlman, Eric; Gillis, Julie; Smalberg, Ira; Terve, Pierre; Zahlmann, Gudrun; Korn, Ron

Application of the Lugano Classification for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The PRoLoG Consensus Initiative (Part 2-Technical)

Lugano 分类在霍奇金淋巴瘤和非霍奇金淋巴瘤的初始评估、分期和疗效评估中的应用:PRoLoG 共识倡议(第 2 部分 - 技术)

Ricard, Fabien; Barrington, Sally; Korn, Ron; Brueggenwerth, Guenther; Trotman, Judith; Cheson, Bruce; Salles, Gilles; Schwartz, Larry; Goldmacher, Greg; Jarecha, Rudresh; Narang, Jayant; Broussais, Florence; Galette, Paul; Liu, Min; Bajpai, Surabhi; Perlman, Eric; Gillis, Julie; Smalberg, Ira; Terve, Pierre; Zahlmann, Gudrun; Schmid, Annette

Anti-CD79B Antibody-Drug Conjugate DCDS0780A in Patients with B-Cell Non-Hodgkin Lymphoma: Phase 1 Dose-Escalation Study

抗CD79B抗体药物偶联物DCDS0780A治疗B细胞非霍奇金淋巴瘤患者:1期剂量递增研究

Herrera, Alex F; Patel, Manish R; Burke, John M; Advani, Ranjana; Cheson, Bruce D; Sharman, Jeff P; Penuel, Elicia; Polson, Andrew G; Liao, Chen Di; Li, Chunze; Schuth, Eva; Vaze, Anjali; Samineni, Divya; Elstrom, Rebecca; Cooper, James; Diefenbach, Catherine

Identification of a genetic signature enriching for response to ibrutinib in relapsed/refractory follicular lymphoma in the DAWN phase 2 trial

在DAWN II期试验中,鉴定出一种与复发/难治性滤泡性淋巴瘤对伊布替尼的反应相关的基因特征

Balasubramanian, Sriram; Hodkinson, Brendan; Schuster, Stephen J; Fowler, Nathan H; Trotman, Judith; Hess, Georg; Cheson, Bruce D; Schaffer, Michael; Sun, Steven; Deshpande, Sanjay; Vermeulen, Jessica; Salles, Gilles; Gopal, Ajay K

Tazemetostat in relapsed/refractory follicular lymphoma: a propensity score-matched analysis of E7438-G000-101 trial outcomes

Tazemetostat治疗复发/难治性滤泡性淋巴瘤:E7438-G000-101试验结果的倾向评分匹配分析

Proudman, David G; Gupta, Deepshekhar; Nellesen, Dave; Yang, Jay; Kamp, Beth A; Mamlouk, Khalid; Cheson, Bruce D